Effect of retention enema with Dahuang Wumei Decoction on intestinal microecological imbalance in patients with HBV-ACLF

The fifth medical center of the General Hospital of the people's Liberation Army of China0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Inpatients who meet the diagnostic criteria of chronic plus acute (subacute) liver failure;
•2. Patients with chronic hepatitis B liver disease;
•3. Patients who voluntarily participated in the study and signed informed consent;
•4. Patients aged 16-65 years.

•Subjects with any of the following conditions will not be able to participate in this study:
•1. Patients with acute liver failure, subacute liver failure and chronic liver failure;
•2. Chronic plus acute (subacute) liver failure caused by non HBV infected patients (including autoimmunity, drug, alcohol, poisoning, parasitism);
•3. Pregnant or lactating women;
•4. Patients with primary liver cancer;
•5. Patients with other serious systemic diseases and psychosis;
•6. Anti HIV positive; patients with hepatitis A, C, D, E virus or cytomegalovirus, EB virus infection;
•7. Patients who used antibiotics, hormones, immunosuppressants, chemotherapy drugs, etc. in the past month;
•8. Patients with severe hemorrhoids, anal stenosis and artificial anus;
•9. Patients with poor compliance cannot guarantee to complete the study according to the study plan;
•10. Patients taking probiotics and other microbial preparations.

发起方

The fifth medical center of the General Hospital of the people's Liberation Army of China